Tarrytown, NY, United States of America

Anthony Marcketta

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Anthony Marcketta: A Pioneer in Hyperglycemia Treatment

Introduction: Anthony Marcketta is a notable inventor residing in Tarrytown, NY, who has made significant contributions to the field of medical science. With a keen focus on treating hyperglycemia, he has developed innovative methods that could transform the way we approach this common health issue. As an inventor, Marcketta holds one patent that showcases his dedication to advancing medical treatments.

Latest Patents: Anthony Marcketta’s patent is titled "Treatment of hyperglycemia with solute carrier family 39 member 5 (SLC39A5) inhibitors." This groundbreaking disclosure provides methods for treating individuals with increased serum glucose levels and/or hyperglycemia. Furthermore, it outlines techniques for identifying subjects at an elevated risk of developing these conditions, along with methods for detecting human Solute Carrier Family 39 Member 5 variant nucleic acid molecules and variant polypeptides. This patent signifies an important step forward in addressing the ever-growing challenge of managing glucose levels in patients.

Career Highlights: Marcketta is currently associated with Regeneron Pharmaceuticals, Inc., an esteemed organization known for its commitment to innovative medical research and development. His work at Regeneron showcases not only his expertise but also his ability to collaborate effectively within a dynamic research environment.

Collaborations: Throughout his career, Anthony has worked alongside prominent colleagues such as Harikiran Nistala and Cristopher Van Hout. These collaborations have likely contributed to enhancing the quality and scope of his research, creating a synergistic effect that fosters innovative thinking and problem-solving in the realm of medical treatments.

Conclusion: Anthony Marcketta's contributions to the field of hyperglycemia treatment underline the importance of innovation in medical research. His patented methods open new avenues for identifying and treating individuals at risk for heightened serum glucose levels. As he collaborates with distinguished colleagues at Regeneron Pharmaceuticals, the future of glucose management looks promising, underscoring the vital role inventors play in advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…